Autologus blood/marrow transplantation. Autologous stem cell transplantation for malignant lymphomas

P. Remenyi, T. Masszi, G. Krivan, V. Goda, M. Reti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

From December 1995 to April 1998, 20 consecutive adult patients suffering from chemosensitive relapse of Hodgkin's or non-Hodgkin lymphoma (11 Hodgkin, 9 non-Hodgkin Lymphoma) received autologous stem cell transplantation. The median follow up period is 15 months (range 6-28). The overall survival is 18/20 (90%), the event free survival is 13/20 (65%). None of the patients died of transplant related cause.

Original languageEnglish
JournalBone Marrow Transplantation
Volume22
Issue numberSUPPL. 4
Publication statusPublished - 1998

Fingerprint

Stem Cell Transplantation
Hodgkin Disease
Non-Hodgkin's Lymphoma
Lymphoma
Transplantation
Bone Marrow
Disease-Free Survival
Transplants
Recurrence
Survival

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Autologus blood/marrow transplantation. Autologous stem cell transplantation for malignant lymphomas. / Remenyi, P.; Masszi, T.; Krivan, G.; Goda, V.; Reti, M.

In: Bone Marrow Transplantation, Vol. 22, No. SUPPL. 4, 1998.

Research output: Contribution to journalArticle

@article{89d98aa573274da187c5eb8baa073693,
title = "Autologus blood/marrow transplantation. Autologous stem cell transplantation for malignant lymphomas",
abstract = "From December 1995 to April 1998, 20 consecutive adult patients suffering from chemosensitive relapse of Hodgkin's or non-Hodgkin lymphoma (11 Hodgkin, 9 non-Hodgkin Lymphoma) received autologous stem cell transplantation. The median follow up period is 15 months (range 6-28). The overall survival is 18/20 (90{\%}), the event free survival is 13/20 (65{\%}). None of the patients died of transplant related cause.",
author = "P. Remenyi and T. Masszi and G. Krivan and V. Goda and M. Reti",
year = "1998",
language = "English",
volume = "22",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "SUPPL. 4",

}

TY - JOUR

T1 - Autologus blood/marrow transplantation. Autologous stem cell transplantation for malignant lymphomas

AU - Remenyi, P.

AU - Masszi, T.

AU - Krivan, G.

AU - Goda, V.

AU - Reti, M.

PY - 1998

Y1 - 1998

N2 - From December 1995 to April 1998, 20 consecutive adult patients suffering from chemosensitive relapse of Hodgkin's or non-Hodgkin lymphoma (11 Hodgkin, 9 non-Hodgkin Lymphoma) received autologous stem cell transplantation. The median follow up period is 15 months (range 6-28). The overall survival is 18/20 (90%), the event free survival is 13/20 (65%). None of the patients died of transplant related cause.

AB - From December 1995 to April 1998, 20 consecutive adult patients suffering from chemosensitive relapse of Hodgkin's or non-Hodgkin lymphoma (11 Hodgkin, 9 non-Hodgkin Lymphoma) received autologous stem cell transplantation. The median follow up period is 15 months (range 6-28). The overall survival is 18/20 (90%), the event free survival is 13/20 (65%). None of the patients died of transplant related cause.

UR - http://www.scopus.com/inward/record.url?scp=0032407212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032407212&partnerID=8YFLogxK

M3 - Article

C2 - 9916651

AN - SCOPUS:0032407212

VL - 22

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - SUPPL. 4

ER -